These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Assessing the effectiveness of household-level focal mass drug administration and community-wide mass drug administration for reducing malaria parasite infection prevalence and incidence in Southern Province, Zambia: study protocol for a community randomized controlled trial. Eisele TP; Silumbe K; Finn T; Chalwe V; Kamuliwo M; Hamainza B; Moonga H; Bennett A; Yukich J; Keating J; Steketee RW; Miller JM Trials; 2015 Aug; 16():347. PubMed ID: 26268804 [TBL] [Abstract][Full Text] [Related]
7. Community-led Responses for Elimination (CoRE): a study protocol for a community randomized controlled trial assessing the effectiveness of community-level, reactive focal drug administration for reducing Plasmodium falciparum infection prevalence and incidence in Southern Province, Zambia. Bridges DJ; Miller JM; Chalwe V; Moonga H; Hamainza B; Steketee R; Silumbe K; Nyangu J; Larsen DA Trials; 2017 Nov; 18(1):511. PubMed ID: 29096671 [TBL] [Abstract][Full Text] [Related]
8. Cluster-randomized trial of monthly malaria prophylaxis versus focused screening and treatment: a study protocol to define malaria elimination strategies in Cambodia. Manning J; Lon C; Spring M; Wojnarski M; Somethy S; Chann S; Gosi P; Soveasna K; Sriwichai S; Kuntawunginn W; Fukuda MM; Smith PL; Rekol H; Sinoun M; So M; Lin J; Satharath P; Saunders D Trials; 2018 Oct; 19(1):558. PubMed ID: 30326952 [TBL] [Abstract][Full Text] [Related]
9. Scale-up of home-based management of malaria based on rapid diagnostic tests and artemisinin-based combination therapy in a resource-poor country: results in Senegal. Thiam S; Thwing J; Diallo I; Fall FB; Diouf MB; Perry R; Ndiop M; Diouf ML; Cisse MM; Diaw MM; Thior M Malar J; 2012 Sep; 11():334. PubMed ID: 23009244 [TBL] [Abstract][Full Text] [Related]
10. Is parasite clearance clinically important after malaria treatment in a high transmission area? A 3-month follow-up of home-based management with herbal medicine or ACT. Willcox ML; Graz B; Diakite C; Falquet J; Dackouo F; Sidibe O; Giani S; Diallo D Trans R Soc Trop Med Hyg; 2011 Jan; 105(1):23-31. PubMed ID: 21056445 [TBL] [Abstract][Full Text] [Related]
11. Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial. Jagannathan P; Kakuru A; Okiring J; Muhindo MK; Natureeba P; Nakalembe M; Opira B; Olwoch P; Nankya F; Ssewanyana I; Tetteh K; Drakeley C; Beeson J; Reiling L; Clark TD; Rodriguez-Barraquer I; Greenhouse B; Wallender E; Aweeka F; Prahl M; Charlebois ED; Feeney ME; Havlir DV; Kamya MR; Dorsey G PLoS Med; 2018 Jul; 15(7):e1002606. PubMed ID: 30016328 [TBL] [Abstract][Full Text] [Related]
13. Profile of Cleft Lip and Cleft Palate at a Public Hospital in Southern India. Prabakaran S; Thilagam KK; Reddy GMM Indian Pediatr; 2019 Sep; 56(9):753-755. PubMed ID: 31638008 [TBL] [Abstract][Full Text] [Related]
15. Improving rational use of ACTs through diagnosis-dependent subsidies: Evidence from a cluster-randomized controlled trial in western Kenya. Prudhomme O'Meara W; Menya D; Laktabai J; Platt A; Saran I; Maffioli E; Kipkoech J; Mohanan M; Turner EL PLoS Med; 2018 Jul; 15(7):e1002607. PubMed ID: 30016316 [TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial. Sagara I; Beavogui AH; Zongo I; Soulama I; Borghini-Fuhrer I; Fofana B; Camara D; Somé AF; Coulibaly AS; Traore OB; Dara N; Kabore MJ; Thera I; Compaore YD; Sylla MM; Nikiema F; Diallo MS; Dicko A; Gil JP; Borrmann S; Duparc S; Miller RM; Doumbo OK; Shin J; Bjorkman A; Ouedraogo JB; Sirima SB; Djimdé AA Lancet Infect Dis; 2016 Feb; 16(2):189-98. PubMed ID: 26601738 [TBL] [Abstract][Full Text] [Related]
17. Patients with positive malaria tests not given artemisinin-based combination therapies: a research synthesis describing under-prescription of antimalarial medicines in Africa. O'Boyle S; Bruxvoort KJ; Ansah EK; Burchett HED; Chandler CIR; Clarke SE; Goodman C; Mbacham W; Mbonye AK; Onwujekwe OE; Staedke SG; Wiseman VL; Whitty CJM; Hopkins H BMC Med; 2020 Jan; 18(1):17. PubMed ID: 31996199 [TBL] [Abstract][Full Text] [Related]
18. Intermittent preventive treatment with dihydroartemisinin-piperaquine and risk of malaria following cessation in young Ugandan children: a double-blind, randomised, controlled trial. Muhindo MK; Jagannathan P; Kakuru A; Opira B; Olwoch P; Okiring J; Nalugo N; Clark TD; Ruel T; Charlebois E; Feeney ME; Havlir DV; Dorsey G; Kamya MR Lancet Infect Dis; 2019 Sep; 19(9):962-972. PubMed ID: 31307883 [TBL] [Abstract][Full Text] [Related]